09 April 2025
: Case report 
Imatinib-Induced Clinical Response in ETV6::ACSL6 Myeloid Neoplasm with Eosinophilic Pneumonitis: A Case Report
Unusual or unexpected effect of treatment
Fieke W. Hoff ADEF 1,2*, Sharon Germans BD 3, Olga K. Weinberg BD 3, Robert H. Collins Jr. BD 1,2, Rolando García
BD 3, Weina Chen BD 3, Miguel D. Cantu BD 3, Mingyi Chen BD 3, Prasad Koduru BD 3, Jeffrey SoRelle BD 3, Yazan F. Madanat ADE 1,2, Stephen S. Chung ADEG 1,2,4
DOI: 10.12659/AJCR.946517
Am J Case Rep 2025; 26:e946517
Figure 3. Graphical visualization of the absolute eosinophil count. Day 0 represent the first day of his hospital admission. High-dose steroids were started at admission and slowly tapered down. On Day 19, imatinib 400 mg daily was given as indicated by the pink bar. The normal absolute eosinophil count (<0.7×109/L) is indicated by the horizontal dashed line in black.